STFC’s Science Programmes are interlinked with universities, national laboratories, international partners, CERN, ESA, ESO, ILL, ESRF and the Diamond Light Source. Through these they promote innovation and routinely engage with industry by either engaging in commercial partnering (through their Business Development Team) or by raising awareness of direct supply opportunities (through their External Innovation Programme).
Their funding schemes, IPS and CLASP, support the flow of technology from STFC-funded research towards commercialisation with innovation partners in academia and industry. The projects they support must be led by an STFC funded research group, either in a university or one of STFC’s laboratories and can be in collaboration with industry. Some schemes are open to all sectors whereas other calls may be focused on providing solutions to particular challenge areas.
They can also help industry and academics to connect through their Innovations Club events and newsletters.
Scottish Health Innovations Ltd, working with NHS Scotland to bring ideas to life.....
Throughout NHS Scotland people are continually coming up with new ideas for improving patient care. Scottish Health Innovations Ltd (SHIL) works alongside NHS Scotland to protect and develop new innovations that come from health care professionals.
By developing these ideas, SHIL creates new products and technologies that will improve patient care and generate financial income for NHS Scotland.
SHIL services include:
· Project management
· Market research
· Sourcing of funding
· Intellectual property protection
· Sourcing of development partners
· Spinout set up
Develops evidence based clinical practice guidelines for the National Health Service in Scotland. SIGN guidelines are derived from a systematic review of the scientific literature and are designed as a vehicle for accelerating the translation of new knowledge into action to meet our aim of reducing variations in practice, and improving patient-important outcomes.
Brings together clinicians and researchers in the field of medical mycology to spawn new initiatives and projects.
To promote clinical and scientific interest in Medical Microbiology in Scotland and to link with other Celtic microbiology associations.
Established in 2007 to enhance capacity in patient safety research in Scotland, the Network involves multidisciplinary research teams from the three centres studying adverse events in the Scottish healthcare system and examining both organisational and professional methods of improving safety.
Hosted by the Scottish Pharmacy Board of the Royal Pharmaceutical Society of Great Britain (RPSGB). Here you'll find all the latest news from the Scottish Pharmacy Board and information about the latest developments in pharmacy in Scotland. You can also find out what's going on in your local branch area, read about best practice in pharmacy, and share your views with others on the discussion forums.
Works with researchers in primary care across Scotland to develop programmes of research, increase study recruitment and increase opportunities for higher level research career opportunities. The prime focus of the SSPC is the conduct of internationally recognised, methodologically rigorous research in primary health care.
Works in partnership with sister organisations and microbiological bodies such as The Federation of European Microbiological Societies and the Biosciences Federation to ensure that microbiology and microbiologists are able to exert influence on policy-makers within the UK, in Europe and world-wide.
Objective is to advance the art and science of microbiology and provides a common meeting ground for scientists working in research and in fields with applications in microbiology, including medicine, veterinary medicine, pharmaceuticals, numerous industries, agriculture, food, the environment and education.
Organized foster the development and application of the science of healthcare epidemiology. It focuses on a variety of disciplines and activities directed at preventing and controlling infections and adverse outcomes and enhancing the quality-of-care.